0
18

In This Issue
  |  
Psychiatric Services

May 01, 2008, Vol. 59, No. 5
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

This Month's Highlights
May 2008: This Month's Highlights
Taking Issue
Lessons to Be Learned From CATIE and CUtLASS
Beverly Jewell Sutton, M.D.
Other Articles
Science and Recovery in Schizophrenia
Jeffrey A. Lieberman, M.D.; Robert E. Drake, M.D., Ph.D.; Lloyd I. Sederer, M.D.; Aysenil Belger, Ph.D.; Richard Keefe, Ph.D.; Diana Perkins, M.D., M.P.H.; Scott Stroup, M.D., M.P.H.
Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements
Michael R. Law, M.Sc.; Dennis Ross-Degnan, Sc.D.; Stephen B. Soumerai, Sc.D.
Utilization and Costs of Antipsychotic Agents: A Canadian Population-Based Study, 1996–2006
Silvia Alessi-Severini, Ph.D.; Robert G. Biscontri, Ph.D.; David M. Collins, Ph.D.; Anita Kozyrskyj, Ph.D.; Jitender Sareen, M.D., F.R.C.P.C.; Murray W. Enns, M.D., F.R.C.P.C.
Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005
Luuk J. Kalverdijk, M.D.; Hilde Tobi, Ph.D.; Paul B. van den Berg, Pharm.D.; Janelle Buiskool, Ph.D.; Leonie Wagenaar, Ph.D.; Ruud B. Minderaa, M.D., Ph.D.; Lolkje T. W. de Jong-van den Berg, Ph.D.
Column
Datapoints: Did CATIE Influence Antipsychotic Use?
Leslie Citrome, M.D., M.P.H.; Ari Jaffe, M.D.; David Martello; Baerbel Allingham, M.S.; Jerome Levine, M.D.
Focus on Mental Health Care Reforms in Europe: Mental Health Services in Europe: An Overview
Matt Muijen, M.D., Ph.D.
Public-Academic Partnerships: The Continuous Improvement for Veterans in Care: Mood Disorders (CIVIC-MD) Study, a VA-Academic Partnership
Amy M. Kilbourne, Ph.D., M.P.H.; Elaine Lasky, R.N.; Harold Alan Pincus, M.D.; C. Bernie Good, M.D., M.P.H.; Susan Cooley, M.N.Ed., A.P.R.N.; Anu Basavaraju, M.A.; Devra Greenwald, M.P.H.; Michael J. Fine, M.D., M.Sc.; Mark S. Bauer, M.D.
Brief Report
Brief Reports: Psychiatric Opinion and Antipsychotic Selection in the Management of Schizophrenia
Melissa R. Arbuckle, M.D., Ph.D.; Marc J. Gameroff, Ph.D.; Steven C. Marcus, Ph.D.; Joyce C. West, Ph.D., M.P.P.; Joshua Wilk, Ph.D.; Mark Olfson, M.D., M.P.H.
Commentary: The Need to Guard Against Pharmaceutical Industry Influence
Robert H. Howland, M.D.
Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006
Michael J. Sernyak, M.D.; Robert A. Rosenheck, M.D.
Mental Health Care Institutions in Nine European Countries, 2002 to 2006
Stefan Priebe, Dr.Med.Habil., F.R.C.Psych.; Patrick Frottier, M.D.; Andrea Gaddini, M.D.; Reinhold Kilian, Ph.D.; Christoph Lauber, M.D.; Rafael Martínez-Leal, M.Sc.; Povl Munk-Jørgensen, M.D.; Dermot Walsh, M.B., F.R.C.P.I.; Durk Wiersma, Ph.D.; Donna Wright, M.Sc.
Commentary: Interpreting Data on "Institutionalization": Not Simply Counting Beds
Matt Muijen, M.D., Ph.D.
Letter
Psychiatric Services 2008 59: 575-575
Psychiatric Services 2008 59: 576-577
Psychiatric Services 2008 59: 576-576
Psychiatric Services 2008 59: 576-576
Psychiatric Services 2008 59: 577-577
Book Review
Psychiatric Services 2008 59: 578-579
Psychiatric Services 2008 59: 578-578
Psychiatric Services 2008 59: 579-580
Psychiatric Services 2008 59: 580-581
Psychiatric Services 2008 59: 580-580
Psychiatric Services 2008 59: 581-582
Psychiatric Services 2008 59: 581-581
Psychiatric Services 2008 59: 582-582
Psychiatric Services 2008 59: 583-583
News and Notes
IOM Warns of Shortfalls in the Workforce That Will Provide Care to the Aging Population
New Briefs
Special Section on Implications of CATIE
Special Section on Implications of CATIE: Introduction to the CATIE Special Section
Marvin S. Swartz, M.D.
Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
Marvin S. Swartz, M.D.; T. Scott Stroup, M.D., M.P.H.; Joseph P. McEvoy, M.D.; Sonia M. Davis, Dr.P.H.; Robert A. Rosenheck, M.D.; Richard S. E. Keefe, Ph.D.; John K. Hsiao, M.D.; Jeffrey A. Lieberman, M.D.
Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?
Marisa Elena Domino, Ph.D.; Marvin S. Swartz, M.D.
Special Section on Implications of CATIE: Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making
Robert A. Rosenheck, M.D.; Douglas L. Leslie, Ph.D.; Jalpa A. Doshi, Ph.D.
Special Section on Implications of CATIE: Policy Toward Second-Generation Antipsychotic Drugs: A Cautionary Note
Richard G. Frank, Ph.D.
Special Section on Implications of CATIE: Lessons to Take Home From CATIE
William T. Carpenter, M.D.; Robert W. Buchanan, M.D.
Special Section on Implications of CATIE: Implications of CATIE for Mental Health Services Researchers
Nancy H. Covell, Ph.D.; Molly T. Finnerty, M.D.; Susan M. Essock, Ph.D.
Special Section on Implications of CATIE: What CATIE Did: Some Thoughts on Implications Deep and Wide
David Cunningham Owens, M.D., F.R.C.Psych.
Special Section on Implications of CATIE: Impact of the CATIE Findings on State Mental Health Policy
Joseph J. Parks, M.D.; Alan Q. Radke, M.D.; Rajiv Tandon, M.D.
Special Section on Implications of CATIE: NAMI Perspective on CATIE: Policy and Research Implications
Kenneth Duckworth, M.D.; Michael J. Fitzpatrick, M.S.W.
  |  
Copyright ©
American
Psychiatric
Association